Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase EARLY_PHASE1 1

Status

Unknown 3Recruiting 2Completed 2Terminated 1

Sponsor Class

OTHER 8

Study Type

Interventional 5Observational 3

Sponsor

Cancer Type

Gastrointestinal 190Breast 111Thoracic 41Genitourinary 37Gynecologic 33Sarcoma 27Head & Neck 27CNS 20Tumor-Agnostic 8Lymphoid 7Plasma cell 6Other solid neoplasm 4Dermatologic 3Other hematologic neoplasm 2Endocrine 1Classical hematology 1

Conditions

Neoplasms 8Neoplasm Metastasis 1

Interventions

pembrolizumab 95Paclitaxel 86Gemcitabine 84Carboplatin 79Surveys and Questionnaires 72Docetaxel 61Bevacizumab 61Nivolumab 59Cisplatin 59Magnetic Resonance Spectroscopy 50Blood Specimen Collection 50Fluorouracil 48Radiotherapy 47Capecitabine 47Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 38Biopsy 36atezolizumab 35Leucovorin 35Pemetrexed 34Standard of Care 32Cetuximab 32Specimen Handling 31Trastuzumab 30Radiosurgery 29Ipilimumab 28Cyclophosphamide 28Interviews as Topic 27olaparib 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Neoadjuvant Therapy × Tumor-Agnostic × Clear all
NCT06417190 2026-05-04

Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology

Cedars-Sinai Medical Center

Phase 2 Recruiting
20 enrolled
Tumor-Agnostic

Neoplasms

NCT02212860 2026-02-11

SIGNAL 2

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Completed
139 enrolled
Tumor-Agnostic

Neoplasms

NCT06831136 2025-09-10

PANCARDINAL-2

The University of Texas Health Science Center, Houston

Phase 2 Recruiting
24 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT02420509 2025-06-04

Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis

University of California, San Diego

Terminated
2 enrolled
Tumor-Agnostic

Neoplasms

NCT03406650 2025-05-04

SAKK 06/17

Swiss Cancer Institute

Phase 2 Completed
61 enrolled
Tumor-Agnostic

Neoplasms

NCT02277938 2021-03-17

Acetylamantadine Excretion by Cancer Patients

University of Manitoba

Unknown
120 enrolled
Tumor-Agnostic

Neoplasms

NCT04031612 2019-07-24

NEOADJ

Centre Georges Francois Leclerc

Unknown
2,000 enrolled
Tumor-Agnostic

Neoplasms

NCT01713218 2012-10-24

NEOPACHI-001

Erasme University Hospital

Phase EARLY_PHASE1 Unknown
21 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡